欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号ES/V/0374/001
药品名称Cryptisel 0.5 mg/ml oral solution for calves
活性成分
    • halofuginone lactate 0.5 mg/ml
剂型Oral solution
上市许可持有人LIVISTO Int’l, S.L. Av. Universitat Autònoma, 29 08290 Cerdanyola del Vallès (Barcelona) Spain
参考成员国 - 产品名称Spain (ES)
Cryptisel 0,5 mg/ml Solución oral para terneros
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
      Cryptisel
    • Netherlands (NL)
    • Ireland (IE)
    • Austria (AT)
      Cryptisel 0,5 mg/ml Lösung zum Eingeben für Kälber
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Cryptisel vet
    • Poland (PL)
    • Latvia (LV)
      Cryptisel 0,5 mg/ml šķīdums iekšķīgai lietošanai teļiem
    • Lithuania (LT)
    • Estonia (EE)
      Cryptisel
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • United Kingdom (Northern Ireland) (XI)
许可日期2020/09/23
最近更新日期2022/03/18
药物ATC编码
    • QP51AX08 halofuginone
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase